• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调控肿瘤中T细胞活性的趋化因子。

Chemokines that govern T cell activity in tumors.

作者信息

Mempel Thorsten R, Malehmir Mohsen

机构信息

Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

出版信息

Curr Opin Immunol. 2025 Feb;92:102510. doi: 10.1016/j.coi.2024.102510. Epub 2024 Dec 11.

DOI:10.1016/j.coi.2024.102510
PMID:39662216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11729545/
Abstract

Local regulation of T cell-mediated immunity to solid tumors occurs at multiple levels, including their recruitment from the bloodstream to the tumor microenvironment (TME), coordinated crosstalk with different subsets of antigen-presenting cells (APCs) controlling their local survival, proliferation, and effector differentiation, as well as their egress from tumors via lymphatics. At each level, chemokines play essential roles, for instance, by guiding directional T cell migration across blood and lymphatic endothelial barriers or by promoting their spatial proximity and direct physical interactions with APCs to enable functional crosstalk. In this article, we will review recent mechanistic insights into the chemokine axes that guide T cell functions in TMEs in light of the emerging functional state heterogeneity of CD8 effector T cells and our growing understanding of how regulatory T cells restrain antitumor activity.

摘要

T细胞介导的针对实体瘤免疫的局部调节发生在多个层面,包括从血液招募至肿瘤微环境(TME)、与不同亚群的抗原呈递细胞(APC)进行协调串扰以控制其局部存活、增殖和效应分化,以及通过淋巴管从肿瘤中逸出。在每个层面,趋化因子都发挥着重要作用,例如,引导T细胞定向迁移穿过血液和淋巴管内皮屏障,或促进其与APC在空间上的接近以及直接的物理相互作用,以实现功能性串扰。在本文中,鉴于CD8效应T细胞新出现的功能状态异质性以及我们对调节性T细胞如何抑制抗肿瘤活性的日益了解,我们将综述关于趋化因子轴引导TME中T细胞功能的最新机制见解。

相似文献

1
Chemokines that govern T cell activity in tumors.调控肿瘤中T细胞活性的趋化因子。
Curr Opin Immunol. 2025 Feb;92:102510. doi: 10.1016/j.coi.2024.102510. Epub 2024 Dec 11.
2
Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception.胰腺腺鳞癌鳞状细胞转化过程中免疫监视功能减弱为癌症拦截提供了新的治疗机会。
J Immunother Cancer. 2025 Jun 23;13(6):e012066. doi: 10.1136/jitc-2025-012066.
3
Depressive Disorder Affects TME and Hormonal Changes Promoting Tumour Deterioration Development.抑郁症影响肿瘤微环境和激素变化,促进肿瘤恶化发展。
Immunology. 2025 Aug;175(4):403-418. doi: 10.1111/imm.13933. Epub 2025 May 8.
4
Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer.负载cDC1特异性趋化因子XCL1的成熟树突状细胞衍生的细胞外囊泡联合化疗诱导的免疫原性细胞死亡用于去势抵抗性前列腺癌的治疗。
Cancer Immunol Immunother. 2025 Jun 18;74(8):242. doi: 10.1007/s00262-025-04070-8.
5
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy.关键免疫T细胞群体在不同免疫原性潜能和免疫治疗反应可能性的恶性肿瘤中的差异浸润。
Cells. 2024 Dec 3;13(23):1993. doi: 10.3390/cells13231993.
6
Mapping immune activity in HPV-negative head and neck squamous cell carcinoma: a spatial multiomics analysis.绘制人乳头瘤病毒阴性头颈部鳞状细胞癌中的免疫活性:一项空间多组学分析
J Immunother Cancer. 2025 Jun 25;13(6):e011851. doi: 10.1136/jitc-2025-011851.
7
Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites.从卵巢肿瘤和恶性腹水中分离出的潜伏感染的EBV阳性抗体分泌B细胞的特征分析。
Front Immunol. 2024 Jul 17;15:1379175. doi: 10.3389/fimmu.2024.1379175. eCollection 2024.
8
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.影响父母和非正式照顾者对常规儿童疫苗接种看法和做法的因素:定性证据综合分析。
Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2.
9
NEDDylation regulates CD8+ T cell metabolism and anti-tumor immunity.NEDDylation调节CD8+ T细胞代谢和抗肿瘤免疫。
Cancer Immunol Res. 2025 Apr 22. doi: 10.1158/2326-6066.CIR-24-0127.
10
The prognostic effect of infiltrating immune cells is shaped by proximal M2 macrophages in lung adenocarcinoma.浸润免疫细胞的预后效应受肺腺癌中近端 M2 巨噬细胞的影响。
Mol Cancer. 2024 Sep 4;23(1):185. doi: 10.1186/s12943-024-02080-1.

引用本文的文献

1
Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives.推进基于嵌合抗原受体(CAR)的实体瘤细胞疗法:挑战、治疗策略及展望
Mol Cancer. 2025 Jul 7;24(1):191. doi: 10.1186/s12943-025-02386-8.

本文引用的文献

1
Pan-cancer mapping of single CD8 T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity.单细胞CD8 T细胞图谱的泛癌图谱揭示了一个调节CD28共刺激和抗肿瘤免疫的TCF1:CXCR6轴。
Cell Rep Med. 2024 Jul 16;5(7):101640. doi: 10.1016/j.xcrm.2024.101640. Epub 2024 Jul 2.
2
TIM-3 CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.TIM-3+CD8 终末耗竭表型 T 细胞在血液恶性肿瘤中保留功能能力。
Sci Immunol. 2024 Apr 19;9(94):eadg1094. doi: 10.1126/sciimmunol.adg1094.
3
Mucosal-associated invariant T cells in cancer: dual roles, complex interactions and therapeutic potential.黏膜相关恒定 T 细胞在癌症中的双重作用、复杂相互作用和治疗潜力。
Front Immunol. 2024 Mar 13;15:1369236. doi: 10.3389/fimmu.2024.1369236. eCollection 2024.
4
The effector program of human CD8 T cells supports tissue remodeling.人类 CD8 T 细胞的效应器程序支持组织重塑。
J Exp Med. 2024 Feb 5;221(2). doi: 10.1084/jem.20230488. Epub 2024 Jan 16.
5
How chemokines organize the tumour microenvironment.趋化因子如何组织肿瘤微环境。
Nat Rev Cancer. 2024 Jan;24(1):28-50. doi: 10.1038/s41568-023-00635-w. Epub 2023 Dec 8.
6
Emergence and fate of stem cell-like CD8 T cells during a primary immune response to viral infection.在病毒感染的初次免疫反应中,干细胞样 CD8 T 细胞的出现和命运。
Sci Immunol. 2023 Nov 17;8(89):eadh3113. doi: 10.1126/sciimmunol.adh3113.
7
CD8 T cells in the cancer-immunity cycle.肿瘤免疫循环中的 CD8 T 细胞。
Immunity. 2023 Oct 10;56(10):2231-2253. doi: 10.1016/j.immuni.2023.09.005.
8
A distinct stimulatory cDC1 subpopulation amplifies CD8 T cell responses in tumors for protective anti-cancer immunity.一种独特的刺激型 cDC1 亚群在肿瘤中扩增 CD8 T 细胞反应,以产生保护性的抗癌免疫。
Cancer Cell. 2023 Aug 14;41(8):1498-1515.e10. doi: 10.1016/j.ccell.2023.06.008. Epub 2023 Jul 13.
9
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8 T cell antitumor immunity.CXCR3 在调节性 T 细胞中的表达驱动其与肿瘤中 I 型树突状细胞的相互作用,从而限制 CD8 T 细胞的抗肿瘤免疫。
Immunity. 2023 Jul 11;56(7):1613-1630.e5. doi: 10.1016/j.immuni.2023.06.003. Epub 2023 Jun 30.
10
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control.T 细胞通过淋巴管的迁出受抗原接触的调控,并限制肿瘤的控制。
Nat Immunol. 2023 Apr;24(4):664-675. doi: 10.1038/s41590-023-01443-y. Epub 2023 Feb 27.